Proton pump inhibitors (PPIs) are essential medications recognized by the World Health Organization (WHO), used as a cornerstone of drug therapy for patients with moderate-to-severe Gastroesophageal Reflux Disease (GERD) symptoms and esophagitis [1,2]. This evidence concerns the gene ATP4A and esophagitis.